Literature DB >> 18508965

Association of incident gout and mortality in dialysis patients.

Scott D Cohen1, Paul L Kimmel, Robert Neff, Lawrence Agodoa, Kevin C Abbott.   

Abstract

Previous studies have shown that gout is associated with an increased risk for cardiovascular mortality in the general population, but this has not been well studied in patients with ESRD. In this study, the incidence of gout and its association with mortality was evaluated in 259,209 patients in the United States Renal Data System. Overall, the incidence of gout in the first year of dialysis was 5% and in the first 5 yr was 15.4%. Independent risk factors for gout in adjusted analyses included black race, older age, female gender, hypertension, ischemic heart disease, congestive heart failure, and alcohol use. Factors associated with a lower risk for gout included a history of diabetes, smoking, and peripheral vascular disease. Time-dependent Cox regression analysis suggested that an episode of gout was independently associated with a 1.5-fold increase in mortality risk (adjusted hazard ratio 1.49; 95% confidence interval 1.43 to 1.55). The mechanisms underlying this association require further study.

Entities:  

Mesh:

Year:  2008        PMID: 18508965      PMCID: PMC2573001          DOI: 10.1681/ASN.2007111256

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  55 in total

Review 1.  Hyperuricemia and renal function.

Authors:  L M Ruilope; J Garcia-Puig
Journal:  Curr Hypertens Rep       Date:  2001-06       Impact factor: 5.369

2.  The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men.

Authors:  Hanna-Maaria Lakka; David E Laaksonen; Timo A Lakka; Leo K Niskanen; Esko Kumpusalo; Jaakko Tuomilehto; Jukka T Salonen
Journal:  JAMA       Date:  2002-12-04       Impact factor: 56.272

3.  Hyperuricemia induces a primary renal arteriolopathy in rats by a blood pressure-independent mechanism.

Authors:  Marilda Mazzali; John Kanellis; Lin Han; Lili Feng; Yi-Yang Xia; Qiang Chen; Duk-Hee Kang; Katherine L Gordon; Susumu Watanabe; Takahiko Nakagawa; Hui Y Lan; Richard J Johnson
Journal:  Am J Physiol Renal Physiol       Date:  2002-06

4.  Familial juvenile gouty nephropathy: exclusion of 16p12 from the candidate locus.

Authors:  Iwao Ohno; Kimiyoshi Ichida; Hideaki Okabe; Maki Moritani; Mitsou Itakura; Masayuki Saito; Naoyuki Kamatani; Tatsuo Hosoya
Journal:  Nephron       Date:  2002       Impact factor: 2.847

5.  Hyperuricemia causes glomerular hypertrophy in the rat.

Authors:  Takahiko Nakagawa; Marilda Mazzali; Duk-Hee Kang; John Kanellis; Susumu Watanabe; Laura G Sanchez-Lozada; Bernardo Rodriguez-Iturbe; Jaime Herrera-Acosta; Richard J Johnson
Journal:  Am J Nephrol       Date:  2003 Jan-Feb       Impact factor: 3.754

6.  Mild hyperuricemia induces glomerular hypertension in normal rats.

Authors:  Laura G Sánchez-Lozada; Edilia Tapia; Carmen Avila-Casado; Virgilia Soto; Martha Franco; José Santamaría; Takahiko Nakagawa; Bernardo Rodríguez-Iturbe; Richard J Johnson; Jaime Herrera-Acosta
Journal:  Am J Physiol Renal Physiol       Date:  2002-11

7.  Serum uric acid and cardiovascular mortality the NHANES I epidemiologic follow-up study, 1971-1992. National Health and Nutrition Examination Survey.

Authors:  J Fang; M H Alderman
Journal:  JAMA       Date:  2000-05-10       Impact factor: 56.272

8.  A role for uric acid in the progression of renal disease.

Authors:  Duk-Hee Kang; Takahiko Nakagawa; Lili Feng; Susumu Watanabe; Lin Han; Marilda Mazzali; Luan Truong; Raymond Harris; Richard J Johnson
Journal:  J Am Soc Nephrol       Date:  2002-12       Impact factor: 10.121

9.  Gout, just a nasty event or a cardiovascular signal? A study from primary care.

Authors:  H J E M Janssens; E H van de Lisdonk; H Bor; H J M van den Hoogen; M Janssen
Journal:  Fam Pract       Date:  2003-08       Impact factor: 2.267

10.  Molecular identification of a danger signal that alerts the immune system to dying cells.

Authors:  Yan Shi; James E Evans; Kenneth L Rock
Journal:  Nature       Date:  2003-09-07       Impact factor: 49.962

View more
  24 in total

Review 1.  Risk factors for gout and prevention: a systematic review of the literature.

Authors:  Jasvinder A Singh; Supriya G Reddy; Joseph Kundukulam
Journal:  Curr Opin Rheumatol       Date:  2011-03       Impact factor: 5.006

2.  The 3-Year Incidence of Gout in Elderly Patients with CKD.

Authors:  Vivian S Tan; Amit X Garg; Eric McArthur; Ngan N Lam; Manish M Sood; Kyla L Naylor
Journal:  Clin J Am Soc Nephrol       Date:  2017-02-02       Impact factor: 8.237

3.  Cause-Specific Mortality in Gout: Novel Findings of Elevated Risk of Non-Cardiovascular-Related Deaths.

Authors:  Ana Beatriz Vargas-Santos; Tuhina Neogi; Geraldo da Rocha Castelar-Pinheiro; Meliha C Kapetanovic; Aleksandra Turkiewicz
Journal:  Arthritis Rheumatol       Date:  2019-09-25       Impact factor: 10.995

4.  Patients and providers view gout differently: a qualitative study.

Authors:  Leslie R Harrold; Kathleen M Mazor; Sarah Velten; Ira S Ockene; Robert A Yood
Journal:  Chronic Illn       Date:  2010-07-30

5.  A meta-analysis of alcohol consumption and the risk of gout.

Authors:  Meiyun Wang; Xiubo Jiang; Wenlong Wu; Dongfeng Zhang
Journal:  Clin Rheumatol       Date:  2013-07-24       Impact factor: 2.980

6.  Single-dose, open-label study of the differences in pharmacokinetics of colchicine in subjects with renal impairment, including end-stage renal disease.

Authors:  Suman Wason; David Mount; Robert Faulkner
Journal:  Clin Drug Investig       Date:  2014-12       Impact factor: 2.859

Review 7.  Hyperuricemia and coronary heart disease: a systematic review and meta-analysis.

Authors:  Seo Young Kim; James P Guevara; Kyoung Mi Kim; Hyon K Choi; Daniel F Heitjan; Daniel A Albert
Journal:  Arthritis Care Res (Hoboken)       Date:  2010-02       Impact factor: 4.794

8.  Risk of end-stage renal disease associated with gout: a nationwide population study.

Authors:  Kuang-Hui Yu; Chang-Fu Kuo; Shue-Fen Luo; Lai-Chu See; I-Jun Chou; Hsiao-Chun Chang; Meng-Jiun Chiou
Journal:  Arthritis Res Ther       Date:  2012-04-18       Impact factor: 5.156

9.  Allopurinol and mortality in hyperuricaemic patients.

Authors:  Andrew J Luk; Gregory P Levin; Elya E Moore; Xiao-Hua Zhou; Bryan R Kestenbaum; Hyon K Choi
Journal:  Rheumatology (Oxford)       Date:  2009-05-15       Impact factor: 7.580

Review 10.  Racial and gender disparities among patients with gout.

Authors:  Jasvinder A Singh
Journal:  Curr Rheumatol Rep       Date:  2013-02       Impact factor: 4.592

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.